by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Maximus Health, Inc. dba Maximus Warning Letter Details

Warning Letter

Maximus Health, Inc. dba Maximus

Maximus Health, Inc. dba Maximus, 2219 Main Street, #347 Santa Monica , CA 90405 United States

Issue DateJune 08, 2026

FEI NumberN/A

Violations2

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

False & Misleading Claims/Misbranded (Telehealth)

Maximus Health, Inc. dba Maximus FDA Warning Letter, June 8, 2026